Brain metastases in HER2-positive metastatic breast cancer patients who received chemotherapy with or without trastuzumab

被引：0
|
作者：
Muhammet Ali Kaplan
Hamza Ertugrul
Ugur Firat
Mehmet Kucukoner
Ali İnal
Zuhat Urakci
Zafer Pekkolay
Abdurrahman Isikdogan
机构：
[1] Dicle University School of Medicine,Department of Medical Oncology
[2] Dicle University School of Medicine,Department of Internal Medicine
[3] Dicle University School of Medicine,Department of Pathology
来源：
Breast Cancer | 2015年 / 22卷
关键词：
Breast cancer; Brain metastasis; Trastuzumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：503 / 509
页数：6
相关论文
共 50 条
  • [1] Brain metastases in HER2-positive metastatic breast cancer patients who received chemotherapy with or without trastuzumab
    Kaplan, Muhammet Ali
    Ertugrul, Hamza
    Firat, Ugur
    Kucukoner, Mehmet
    Inal, Ali
    Urakci, Zuhat
    Pekkolay, Zafer
    Isikdogan, Abdurrahman
    BREAST CANCER, 2015, 22 (05) : 503 - 509
  • [2] HER2-positive breast cancer brain metastases: multiple responses to systemic chemotherapy and trastuzumab - a case report
    Church, D. N.
    Bahl, A.
    Jones, A.
    Price, C. G. A.
    JOURNAL OF NEURO-ONCOLOGY, 2006, 79 (03) : 289 - 292
  • [3] HER2-positive Breast Cancer Brain Metastases: Multiple Responses to Systemic Chemotherapy and Trastuzumab—a Case Report
    D. N. Church
    A. Bahl
    A. Jones
    C. G. A. Price
    Journal of Neuro-Oncology, 2006, 79 : 289 - 292
  • [4] Trastuzumab beyond progression in HER2-positive metastatic breast cancer
    Al-Naqqash, Manwar
    Jasim Al-Serarati, Waleed
    Farooq Kareem, Tara
    BREAST JOURNAL, 2021, 27 (03) : 297 - 299
  • [5] Role of trastuzumab in the management of HER2-positive metastatic breast cancer
    Milani, Andrea
    Montemurro, Filippo
    Gioeni, Luisa
    Aglietta, Massimo
    Valabrega, Giorgio
    BREAST CANCER-TARGETS AND THERAPY, 2010, 2 : 93 - 109
  • [6] Paclitaxel, carboplatin, and trastuzumab in HER2-positive metastatic breast cancer
    Andrew D. Seidman
    Larry Norton
    Current Oncology Reports, 2005, 7 (1) : 9 - 11
  • [7] A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer
    Macpherson, Iain R.
    Spiliopoulou, Pavlina
    Rafii, Saeed
    Saggese, Matilde
    Baird, Richard D.
    Garcia-Corbacho, Javier
    Italiano, Antoine
    Bonneterre, Jacques
    Campone, Mario
    Cresti, Nicola
    Posner, John
    Takeda, Yousuke
    Arimura, Akinori
    Spicer, James
    BREAST CANCER RESEARCH, 2019, 22 (01)
  • [8] A phase I/II study of epertinib plus trastuzumab with or without chemotherapy in patients with HER2-positive metastatic breast cancer
    Iain R. Macpherson
    Pavlina Spiliopoulou
    Saeed Rafii
    Matilde Saggese
    Richard D. Baird
    Javier Garcia-Corbacho
    Antoine Italiano
    Jacques Bonneterre
    Mario Campone
    Nicola Cresti
    John Posner
    Yousuke Takeda
    Akinori Arimura
    James Spicer
    Breast Cancer Research, 22
  • [9] Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer
    Makiko Ono
    Masashi Ando
    Mayu Yunokawa
    Eriko Nakano
    Kan Yonemori
    Koji Matsumoto
    Tsutomu Kouno
    Chikako Shimizu
    Kenji Tamura
    Noriyuki Katsumata
    Yasuhiro Fujiwara
    International Journal of Clinical Oncology, 2009, 14 : 48 - 52
  • [10] Brain metastases in patients who receive trastuzumab-containing chemotherapy for HER2-overexpressing metastatic breast cancer
    Ono, Makiko
    Ando, Masashi
    Yunokawa, Mayu
    Nakano, Eriko
    Yonemori, Kan
    Matsumoto, Koji
    Kouno, Tsutomu
    Shimizu, Chikako
    Tamura, Kenji
    Katsumata, Noriyuki
    Fujiwara, Yasuhiro
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2009, 14 (01) : 48 - 52
12345